DAXXIFY® is a prescription injectable treatment used in adults to temporarily improve the look of moderate to severe frown lines between the eyebrows. As the first and only FDA-approved peptide-formulated neuromodulator for glabellar lines, it offers an advanced option for patients seeking a smoother, more refreshed appearance. DAXXIFY® is designed for professional aesthetic use and can be incorporated into a personalized treatment plan based on each patient’s cosmetic goals and individual needs. With its peptide-powered formulation, DAXXIFY® provides a modern approach to softening dynamic wrinkles caused by repeated facial expressions. Treatment is tailored to each patient to help create natural-looking results that enhance the appearance without looking overdone. For those looking to reduce the appearance of frown lines and achieve a smoother, more youthful look, DAXXIFY® offers a refined solution that fits easily into a customized aesthetic plan.